EMERYVILLE, Calif., Oct. 10, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leader in the development and production of sustainable products for Health and Clean Beauty, today announced the successful launch of its Pipette brand on Amazon.com.

WEST CHESTER, Pa., Oct. 10, 2019 /PRNewswire/ -- Children's Dental Management, a leading Dental Support Organization (DSO) serving more than

BOZEMAN, Mont., Oct. 10, 2019 /PRNewswire/ -- SiteOne Therapeutics, a privately-held biopharmaceutical company advancing novel non-opioid pain therapeutics, today announced that it has received a Notice of Award from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) for grant funding under the Helping to End Addiction Long-term, or th

BEVERLY, Mass., Oct. 10, 2019 /PRNewswire/ -- Stilla Technologies, the provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, announced today that it is establishing a new U.S. subsidiary to enable direct commercial operations and distribution in the Americas with the opening of headquarters in Beverly, Massachu

NEW YORK, Oct. 10, 2019 /PRNewswire/ -- Tempest, the virtual program changing how individuals access recovery, has completed a $10 million Series A round of financin

STAMFORD, Conn., Oct. 10, 2019 /PRNewswire/ -- TECLens, a medical device manufacturer, today announced the completion of enrollment of its pilot clinical study for the treatment of Keratoconus using the TECLens' CXLens® 'on-eye' cross-linking system for corneal remodeling. Clinical trial results are anticipated in early 2020.

DOVER, Mass., Oct. 10, 2019 /PRNewswire/ -- Backpack Health, a free mobile and web-based multilingual digital platform giving users control of their health data with continuous and sharabl

LOS ANGELES, Oct. 10, 2019 /PRNewswire/ -- Award-winning wellness company dosist today announced the launch of its revolutionary new product, the dose dial™, the first dose-controlle

JERUSALEM, Oct. 10, 2019 /PRNewswire/ -- Future Meat Technologies today announced it has closed a $14 million Series A funding round led by S2G Ventures, a Chicago-based venture capital firm and one of the forces behind Beyond Meat's IPO, and Emerald Technology Ventures, a Swiss-based ven

SAN DIEGO, Oct. 10, 2019 /PRNewswire/ -- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced Kerry Ingalls has joined the company as Chief Operating Officer. In this role, Ingalls will work closely with